Podchaser Logo
Home
Pfizer, Cerevel, Abbott, AstraZeneca + Daiichi Sankyo

Pfizer, Cerevel, Abbott, AstraZeneca + Daiichi Sankyo

Released Tuesday, 16th August 2022
Good episode? Give it some love!
Pfizer, Cerevel, Abbott, AstraZeneca + Daiichi Sankyo

Pfizer, Cerevel, Abbott, AstraZeneca + Daiichi Sankyo

Pfizer, Cerevel, Abbott, AstraZeneca + Daiichi Sankyo

Pfizer, Cerevel, Abbott, AstraZeneca + Daiichi Sankyo

Tuesday, 16th August 2022
Good episode? Give it some love!
Rate Episode

Spending that COVID money, brain money, Irish money, and another oncology approval.

Find out more at
https://LifeScienceTodayPodcast.com

Story References
Pfizer
Cerevel
Abbott
AstraZeneca + Daiichi Sankyo

About the Show
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry. 

Show More

Unlock more with Podchaser Pro

  • Audience Insights
  • Contact Information
  • Demographics
  • Charts
  • Sponsor History
  • and More!
Pro Features